🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy and safety of PEG-rhG-...
Status
Unknown
Location
Multiple Locations
Start Date
2021-12
Trial ID
NCT05156554
Treatments Being Tested
The primary objective of this protocol is to evaluate the response rate of ...
Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2013-06-19
Trial ID
NCT01783535
The purpose of this study is to estimate the safety and efficacy of PEG-rhG...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT02805166
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Rebecca and John Moores UCSD Cancer Center
Start Date
2007-01
Trial ID
NCT00389818
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Start Date
2005-09
Trial ID
NCT00101010
The goal of this clinical research study is to learn if using a combination...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2005-03-14
Trial ID
NCT00254410
Treatments Being Tested
This study is to examine which dose of DA-3031(PEG-G-CSF) has similar effic...
Status
Completed
Location
Korea University GURO hospital
Start Date
2010-07
Trial ID
NCT01923545
To learn if cyclophosphamide, vincristine, and dexamethasone (called mini h...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-07-14
Trial ID
NCT05645718
Neutropenia is one of the most frequent adverse effects of chemotherapy, an...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2012-04
Trial ID
NCT01560195
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of T...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2025-06-12
Trial ID
NCT06926751
Treatments Being Tested